Chloroquine and Hydroxychloroquine for the Prevention and Treatment of COVID-19: A Fiction, Hope or Hype? An Updated Review
Sultan AM Saghir,1 Naif A AlGabri,2,3 Mahmoud M Alagawany,4 Youssef A Attia,5,6 Salem R Alyileili,7 Shaaban S Elnesr,8 Manal E Shafi,9 Omar YA Al-shargi,10 Nader Al-balagi,11 Abdullah S Alwajeeh,12 Omar SA Alsalahi,13 Amlan K Patra,14 Asmaa F Khafaga,15 Ahmed Negida,16,17 Ahmed Noreldin,18 Wesam Al-...
Guardado en:
Autores principales: | Saghir SAM, AlGabri NA, Alagawany MM, Attia YA, Alyileili SR, Elnesr SS, Shafi ME, Al-shargi OYA, Al-balagi N, Alwajeeh AS, Alsalahi OS, Patra AK, Khafaga AF, Negida A, Noreldin A, Al-Amarat W, Almaiman AA, El-Tarabily KA, Abd El-Hack ME |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c656298cb1cb41bd908f16121713630e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Incidence of and risk factors for chloroquine and hydroxychloroquine retinopathy in Thai rheumatologic patients
por: Tangtavorn N, et al.
Publicado: (2016) -
Therapeutic Potential of Thymoquinone and Its Nanoformulations in Pulmonary Injury: A Comprehensive Review
por: Al-Gabri NA, et al.
Publicado: (2021) -
Clinical Efficacy of Hydroxychloroquine or Chloroquine in Patients with COVID-19: An Umbrella Review
por: Kavous Shahsavarinia, et al.
Publicado: (2021) -
Systematic review and meta-analysis of the safety of chloroquine and hydroxychloroquine from randomized controlled trials on malarial and non-malarial conditions
por: Mayra Souza Botelho, et al.
Publicado: (2021) -
Narrative Review: Risk-Benefit Hydroxychloroquine and Chloroquine in COVID-19
por: Jarir At Thobari
Publicado: (2021)